EP Patent

EP3895692A1 — Oral thin film with smooth fused film

Assigned to LTS Lohmann Therapie Systeme AG · Expires 2021-10-20 · 5y expired

What this patent protects

The invention relates to an oral thin film, comprising a polymer matrix and at least one water-insoluble, particulate active pharmaceutical ingredient dispersed in the polymer matrix, wherein the matrix polymer is poly(ethylene oxide) having a melting point of at least 55 °C, the…

USPTO Abstract

The invention relates to an oral thin film, comprising a polymer matrix and at least one water-insoluble, particulate active pharmaceutical ingredient dispersed in the polymer matrix, wherein the matrix polymer is poly(ethylene oxide) having a melting point of at least 55 °C, the amount of poly(ethylene oxide) having a melting point of at least 55 °C is at least 40% by weight, based on the total weight of the oral thin film, and wherein the oral thin film is obtainable by a process comprising the steps of: a) preparing a suspension comprising the matrix polymer, the at least one water-insoluble, particulate active pharmaceutical ingredient and a solvent which is water or a mixture of water and one or more organic solvents, b) casting the suspension obtained on a support or in a mold, and c) drying the suspension at a temperature above the melting temperature of the poly(ethylene oxide) to obtain the oral thin film.The oral thin film is suitable as a medicament and can be administered in the oral cavity without addition of drinking water. The oral thin film has a very smooth surface providing a good mouth feel. Moreover, an enhanced protection of the active pharmaceutical ingredient against external influences is achieved.

Drugs covered by this patent

Patent Metadata

Patent number
EP3895692A1
Jurisdiction
EP
Classification
Expires
2021-10-20
Drug substance claim
No
Drug product claim
No
Assignee
LTS Lohmann Therapie Systeme AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.